Harvard University Shield

Home Research Program Faculty Curriculum Clinical Experience Minority Information How To Apply Alumni

Contact Information:
Harvard Medical School
Fellowship in General
Medicine and Primary Care
Beth Israel Deaconess
Medical Center
1309 Beacon Street CO-211
Brookline, MA 02446

Tel (617) 754-1448
Fax (617) 754-1440
Email: GIM Fellowship
Harvard Medical School

Brigham and Women’s Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics

Aaron S. Kesselheim, M.D., J.D., M.P.H.
Aaron S. Kesselheim, M.D., J.D., M.P.H. diamond
Fellowship Site Director
Associate Professor of Medicine, Harvard Medical School

Dr. Kesselheim’s research focuses on the effects of intellectual property laws and regulatory policies on pharmaceutical development, the drug approval process, and the costs, availability, and use of prescription drugs both domestically and in resource-poor settings. He has also investigated how other issues at the intersection of law and public health can affect the health care system, including health care fraud, expert testimony in malpractice cases, and insurance reimbursement practices. He is a member of the New York State Bar and is a Patent Attorney. Within the Division, Dr. Kesselheim leads the Program On Regulation, Therapeutics, And Law (PORTAL), an interdisciplinary research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law. In 2013, Dr. Kesselheim was named a Greenwall Faculty Scholar in Bioethics by the Greenwall Foundation, which supports innovative empirical research in bioethics. Dr. Kesselheim’s work is also currently funded by the FDA and the Harvard Program in Therapeutic Science. In the past, he has received research support from the Agency for Healthcare Research and Quality, a Robert Wood Johnson Investigator Award in Health Policy Research, the Edmond J. Safra Center for Ethics at Harvard University, Pew Charitable Trusts, and the Harvard Clinical and Translational Science Center. In 2012, he was named to the Perspectives Advisory Board of the New England Journal of Medicine. He has testified before Congress on pharmaceutical policy, medical device regulation, generic drugs, and modernizing clinical trials, and served as a consultant for the NIH, FDA, Institute of Medicine, USPTO, and numerous state government offices. Dr. Kesselheim also serves as a faculty supervisor for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, a faculty member of the Harvard Center for Bioethics, and a Research Associate in the Department of Health Policy and Management at the Harvard School of Public Health. In the 2016-2017 academic year, he is a Visiting Associate Professor of Law at Yale Law School, where taught Food and Drug Administration Law. He serves as a primary care physician at the Phyllis Jen Center for Primary Care at BWH.

Jerry Avorn, M.D.
Jerry Avorn, M.D.
Division Chief, Pharmacoepidemiology and Pharmacoeconomics
Professor of Medicine, Harvard Medical School

Dr. Jerry Avorn is internist, geriatrician, and drug epidemiologist, and he studies the intended and adverse effects of drugs, physician prescribing practices, and medication policy. His major areas of research include: the scientific, policy, and social factors that shape physicians’ drug choices; medication compliance by patients; the identification and prevention of adverse drug effects; programs to improve the appropriateness of prescribing and drug taking; and pharmaceutical cost-effectiveness analysis. Dr. Avorn pioneered the “academic detailing” approach in which evidence-based information about drugs is provided to doctors through educational outreach programs run by non-commercial sponsors; such programs are now in widespread use throughout the U.S., Canada, Australia, Europe, and the developing world. Dr. Avorn has served on several national and international panels as an expert on the determinants and consequences of medication use, and is a past President of the International Society of Pharmaco-Epidemiology. Dr. Avorn is the author of over 500 papers in the medical literature on medication use and its outcomes, and is one of the most highly-cited researchers working in the area of medicine and the social sciences. His book, Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, was published by Knopf in 2005.

Sebastian Schneeweiss, M.D., Sc.D.
Sebastian Schneeweiss, M.D., Sc.D.
Division Vice-Chief, Pharmacoepidemiology and Pharmacoeconomics
Professor of Medicine and Epidemiology, Harvard Medical School

Dr. Schneeweiss’s research is funded by multiple NIH grants and focuses on the comparative effectiveness and safety of biopharmaceuticals and analytic methods to improve the validity of epidemiologic studies using complex healthcare databases. He is Principal Investigator of the BWH DEcIDE Research Center on Comparative Effectiveness Research and the DEcIDE Methods Center both funded by AHRQ and Director of the Harvard-Brigham Drug Safety Research Center funded by FDA/CDER. Dr. Schneeweiss is Past President of the International Society for Pharmacoepidemiology and is Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology. He is voting consultant to the FDA Drug Safety and Risk Management Advisory Committee and member of the Methods Committee of the Patient Centered Outcomes Research Institute. He received his medical training at the University of Munich Medical School and his doctoral degree in Pharmacoepidemiology from Harvard.

Brian T. Bateman, M.D.
Assistant Professor of Anesthesia, Harvard Medical School
Niteesh K. Choudhry, M.D., Ph.D.
Associate Professor of Medicine, Harvard Medical School
Michael A. Fischer, M.D., M.S.
Associate Professor of Medicine, Harvard Medical School
Jessica M. Franklin, Ph.D.
Assistant Instructor of Medicine, Harvard Medical School
Joshua J. Gagne, Pharm.D., Sc.D.
Assistant Professor of Medicine, Harvard Medical School
Robert J. Glynn, Ph.D., Sc.D.
Professor of Medicine (in Biostatistics), Harvard Medical School
Associate Professor of Biostatistics, Harvard School of Public Health
Krista F. Huybrechts, M.S., Ph.D.
Assistant Professor of Medicine, Harvard Medical School
Seo Young Kim, M.D., M.S.C.E.
Assistant Professor of Medicine, Harvard Medical School
Jing Luo, MD, MPH diamond
Instructor in Medicine, Harvard Medical School
Ameet Sarpatwari, PhD, JD
Instructor in Medicine, Harvard Medical School
Daniel H. Solomon, M.D., M.P.H.
Professor of Medicine, Harvard Medical School
diamond Denotes faculty who have graduated from the Fellowship Program

Copyright © 2017 by the President and Fellows of Harvard College